Table of Contents
1. Executive Summary
2. Market Background and Classifications
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. Market Trends and Forecast Analysis from 2014 to 2025
3.1: Macroeconomic Trends and Forecast
3.2: Global Sequencing Market Trends and Forecast
3.3: Global Sequencing Market by Product
3.3.1: Consumables
3.3.2: Instruments
3.3.3: Services
3.4: Global Sequencing Market by Technology
3.4.1: Sequencing by Synthesis
3.4.2: Ion Semiconductor Sequencing
3.4.3: Sequencing by ligation
3.4.4: Pyrosequencing
3.4.5: Single-molecule Real-time Sequencing
3.4.6: Chain Termination Technology
3.4.7: Nanopore Sequencing
3.5: Global Sequencing Market by Platform
3.5.1: Sanger
3.5.2: Next Generation Sequencing
3.5.3: PCR
3.5.4: Others
3.6: Global Sequencing Market by Application
3.6.1: Biomarker & Cancer
3.6.2: Diagnostics
3.6.3: Reproductive Health
3.6.4: Personalized Medicine
3.6.5: Forensics
3.6.6: Others
3.7: Global Sequencing Market by End User
3.7.1: Academic & Government Research Institutes
3.7.2: Pharmaceutical Companies
3.7.3: Biotechnology Companies
3.7.4: Hospitals & Clinics
3.7.5: Others
4. Market Trends and Forecast Analysis by Region
4.1: Global Sequencing Market by Region
4.2: North American Sequencing Market
4.2.1: Market by Product: Consumables, Instruments, and Services
4.2.2: Market by Technology: Sequencing by Synthesis, Ion Semiconductor Sequencing, Sequencing by ligation, Pyrosequencing, Single-molecule Real-time Sequencing, Chain Termination Technology, and Nanopore Sequencing
4.2.3: Market by Platform: Sanger, Next Generation Sequencing, qPCR, and Others
4.2.4: Market by Application: Biomarker & Cancer, Diagnostics, Reproductive Health, Personalized Medicine, Forensics, and Others
4.2.5: Market by End User: Academic & Government Research Institutes, Pharmaceutical Companies, Biotechnology Companies, Hospitals & Clinics, and Others
4.2.6: The United States Sequencing Market
4.2.7: The Canadian Sequencing Market
4.2.8: The Mexican Sequencing Market
4.3: European Sequencing Market
4.3.1: Market by Product: Consumables, Instruments, and Services
4.3.2: Market by Technology: Sequencing by Synthesis, Ion Semiconductor Sequencing, Sequencing by ligation, Pyrosequencing, Single-molecule Real-time Sequencing, Chain Termination Technology, and Nanopore Sequencing
4.3.3: Market by Platform: Sanger, Next Generation Sequencing, qPCR, and Others
4.3.4: Market by Application: Biomarker & Cancer, Diagnostics, Reproductive Health, Personalized Medicine, Forensics, and Others
4.3.5: Market by End User: Academic & Government Research Institutes, Pharmaceutical Companies, Biotechnology Companies, Hospitals & Clinics, and Others
4.3.6: The Sequencing Market of the United Kingdom
4.3.7: The Spanish Sequencing Market
4.3.8: The German Sequencing Market
4.4: APAC Sequencing Market
4.4.1: Market by Product: Consumables, Instruments, and Services
4.4.2: Market by Technology: Sequencing by Synthesis, Ion Semiconductor Sequencing, Sequencing by ligation, Pyrosequencing, Single-molecule Real-time Sequencing, Chain Termination Technology, and Nanopore Sequencing
4.4.3: Market by Platform: Sanger, Next Generation Sequencing, qPCR, and Others
4.4.4: Market by Application: Biomarker & Cancer, Diagnostics, Reproductive Health, Personalized Medicine, Forensics, and Others
4.4.5: Market by End User: Academic & Government Research Institutes, Pharmaceutical Companies, Biotechnology Companies, Hospitals & Clinics, and Others
4.4.6: The Chinese Sequencing Market
4.4.7: The Indian Sequencing Market
4.4.8: The Japanese Sequencing Market
4.5: ROW Sequencing Market
4.5.1: Market by Product: Consumables, Instruments, and Services
4.5.2: Market by Technology: Sequencing by Synthesis, Ion Semiconductor Sequencing, Sequencing by ligation, Pyrosequencing, Single-molecule Real-time Sequencing, Chain Termination Technology, and Nanopore Sequencing
4.5.3: Market by Platform: Sanger, Next Generation Sequencing, qPCR, and Others
4.5.4: Market by Application: Biomarker & Cancer, Diagnostics, Reproductive Health, Personalized Medicine, Forensics, and Others
4.5.5: Market by End User: Academic & Government Research Institutes, Pharmaceutical Companies, Biotechnology Companies, Hospitals & Clinics, and Others
4.5.6: Brazilian Sequencing Market
5. Competitor Analysis
5.1: Market Share Analysis
5.2: Product Portfolio Analysis
5.3: Operational Integration
5.4: Geographical Reach
5.5: Porter’s Five Forces Analysis
6. Cost Structure Analysis
6.1: Cost of Goods Sold
6.2: SG&A
6.3: EBITDA Margin
7. Growth Opportunities and Strategic Analysis
7.1: Growth Opportunity Analysis
7.1.1: Growth Opportunities for the Global Sequencing Market by Product
7.1.2: Growth Opportunities for the Global Sequencing Market by Technology
7.1.3: Growth Opportunities for the Global Sequencing Market by Platform
7.1.4: Growth Opportunities for the Global Sequencing Market by Application
7.1.5: Growth Opportunities for the Global Sequencing Market by End User
7.1.6: Growth Opportunities for the Global Sequencing Market by Region
7.2: Emerging Trends in the Global Sequencing Market
7.3: Strategic Analysis
7.3.1: New Product Development
7.3.2: Capacity Expansion of the Global Sequencing Market
7.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Sequencing Market
7.3.4: Certification and Licensing
8. Company Profiles of Leading Players
8.1: Abbott Laboratories
8.2: Agilent Technologies, Inc.
8.3: Danaher Corporation
8.4: F. Hoffmann-La Roche Ltd.
8.5: Illumina, Inc.
8.6: LI-COR Biosciences, Inc.
8.7: Pacific Biosciences of California, Inc.
8.8: Siemens AG
8.9: PerkinElmer Inc.
8.10: Thermo Fisher Scientific, Inc